ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007